NASDAQ:PBM - Nasdaq - CA74449F1009 - Common Stock - Currency: USD
PSYENCE BIOMEDICAL LTD
NASDAQ:PBM (1/28/2025, 6:13:07 PM)
After market: 1.4399 +0.1 (+7.46%)1.34
-0.34 (-20.24%)
The current stock price of PBM is 1.34 USD. In the past month the price decreased by -43.93%. In the past year, price decreased by -98.77%.
NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that it has closed...
NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company“) today announced that it has entered...
Company poised to enter 2025 with cash position of $5.6 million and debt-free balance sheet...
Patient screening underway; first patient expected to be randomized into the study in January A leading clinical trial site management organization (SMO),...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 16.26 | 308.91B | ||
AMGN | AMGEN INC | 14.58 | 150.67B | ||
GILD | GILEAD SCIENCES INC | 21.19 | 116.96B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 864.08 | 113.49B | ||
REGN | REGENERON PHARMACEUTICALS | 15.11 | 75.42B | ||
ARGX | ARGENX SE - ADR | N/A | 38.75B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 36.01B | ||
BNTX | BIONTECH SE-ADR | N/A | 29.96B | ||
ONC | BEIGENE LTD-ADR | N/A | 24.13B | ||
NTRA | NATERA INC | N/A | 22.19B | ||
BIIB | BIOGEN INC | 8.91 | 21.20B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.33B |
Psyence Biomedical Ltd. is a life science biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
PSYENCE BIOMEDICAL LTD
121 Richmond Street West Penthouse, Suite 1300
TORONTO ONTARIO V6E 3Z3 CA
CEO: John Plourde
Employees: 0
Company Website: http://psyence.com
Investor Relations: http://psyence.com/investors/
Phone: 17744604171
The current stock price of PBM is 1.34 USD.
The exchange symbol of PSYENCE BIOMEDICAL LTD is PBM and it is listed on the Nasdaq exchange.
PBM stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PBM, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PBM.
PBM does not pay a dividend.
The outstanding short interest for PBM is 10.15% of its float.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |